ChemicalBook >
Produktkatalog >
Pharmazeutische Zwischenprodukte >
Zwischenprodukte der aktiven pharmazeutischen Wirkstoffen (APIs) >(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
CAS-Nr.
179324-87-9
Englisch Name:
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
Synonyma:
(1R)-(S)-PINANEDIOL 1-AMMONIUM TRIFLUOROACETATE-3-METHYLBUTANE-1-BORONATE;(R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-triMethylhexahydro-4,6-Methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-aMine 2,2,2-trifluoroacetate;2,6<SUP>/SUP>(R)-BoroL;6-methano-1;Bortezomib INT A;eu-(+)-PinanedioL;7aR)-Hexahydro-3a
CBNumber:
CB21511721
Summenformel:
C17H29BF3NO4
Molgewicht:
379.23
MOL-Datei:
179324-87-9.mol
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Eigenschaften
Schmelzpunkt:
157-159°C
storage temp.
under inert gas (nitrogen or Argon) at 2-8°C
L?slichkeit
Ethanol (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
Farbe
White to Off-White
InChI
InChI=1/C15H28BNO2.C2HF3O2/c1-9(2)6-13(17)16-18-12-8-10-7-11(14(10,3)4)15(12,5)19-16;3-2(4,5)1(6)7/h9-13H,6-8,17H2,1-5H3;(H,6,7)/t10-,11-,12+,13-,15-;/s3
InChIKey
SRFQKJZNJYTMNI-XXOUUVOINA-N
SMILES
C(F)(F)(F)C(=O)O.C[C@@]12OB([C@@H](N)CC(C)C)O[C@]1([H])C[C@]1([H])C[C@@]2([H])C1(C)C |&1:8,11,18,21,24,r|
CAS Datenbank
179324-87-9(CAS DataBase Reference)
Sicherheit
Risiko- und Sicherheitserkl?rung
Gefahreninformationscode (GHS)
Bildanzeige (GHS)
Alarmwort
Warnung
Gefahrenhinweise
Code
Gefahrenhinweise
Gefahrenklasse
Abteilung
Alarmwort
Symbol
P-Code
H302
Gesundheitssch?dlich bei Verschlucken.
Akute Toxizit?t oral
Kategorie 4
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P270, P301+P312, P330, P501
H315
Verursacht Hautreizungen.
Hautreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P302+P352, P321,P332+P313, P362
H319
Verursacht schwere Augenreizung.
Schwere Augenreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P305+P351+P338,P337+P313P
H332
Gesundheitssch?dlich bei Einatmen.
Akute Toxizit?t inhalativ
Kategorie 4
Warnung
src="/GHS07.jpg" width="20" height="20" />
P261, P271, P304+P340, P312
H335
Kann die Atemwege reizen.
Spezifische Zielorgan-Toxizit?t (einmalige Exposition)
Kategorie 3 (Atemwegsreizung)
Warnung
src="/GHS07.jpg" width="20" height="20" />
Sicherheit
P261
Einatmen von Staub vermeiden.
P280
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P305+P351+P338
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
Verwenden
Bortezomib (B675700) intermediate. A boronic acid dipeptide derivative as proteasome inhibitors.
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 344)Lieferanten
Canada 1
CHINA 317
France 1
India 14
United Kingdom 2
United States 9
Global 344
Firmenname
Telefon
E-Mail
Land
Produktkatalog
Edge Rate
Zhengzhou Anbu Chem Co.,Ltd
+86-0371-88006763; +8615988602810
sales@anbuchem.com
China
2998
58
SHANDONG BOYUAN PHARMACEUTICAL CO., LTD.
+86-0531-69954981 +8615666777973
dwyane.wang@boyuanpharm.com
China
211
58
Cangzhou Kangrui Pharma Tech Co. Ltd.,
+86-18632776803 +86-13833998158
cangzhoukangrui@126.com
China
738
58
Sinoway Industrial co., ltd.
0592-5800732; +8613806035118
xie@china-sinoway.com
China
988
58
Henan Fengda Chemical Co., Ltd
+86-371-86557731 +86-13613820652
info@fdachem.com
China
20267
58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618092446649
sarah@tnjone.com
China
1143
58
Capot Chemical Co.,Ltd.
+86-(0)57185586718 +86-13336195806
sales@capot.com
China
29793
60
Shanghai Daken Advanced Materials Co.,Ltd
+86-371-66670886
info@dakenam.com
China
18941
58
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497
sales01@cooperate-pharm.com
CHINA
1803
55
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com
China
21634
55
179324-87-9()Verwandte Suche:
(R)-BoroLeu-(+)-Pinanediol-CF3COOH
(R)-BoroLeu-(+)-Pinanediol-CF3CO2H
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate
Bortezomib Intermediate 1
(R)-BoroLeu-(+)-Pinanediol trifluoroacetate
(αR,3aS,4S,6S,7aR)-
(alphaR,3as,4s,6s,7ar)-Hexahydro-3a,8,8-triMethyl-alpha-(2-Methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine 2,2,2-trifluoroacetate
Pinanedioltrifluoroacetate salt-
BortezoMib I(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-triMethyl-alpha-(2-Methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine 2,2,2-trifluoroacetate
(R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-triMethylhexahydro-4,6-Methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-aMiniuM 2,2,2-trifluoroacetate
(αR)-(1S,2S,3R,5S)-Pinanediol-1-aMino-3-Methylbutane-1-boronate Trifluoroacetic Acid Salt
(R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate
Bortezomib Intermediates
Ixazomib intermediate
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methamine 2,2,2-trifluoroacetate
Bortezomib INT A
(R)-BoroLeu-(+)-Pinanediol-CF3COOH N-4
(1R)-(S)-pinanediol 1-aMMoniuM trifiuoroacetate-3-Methylbutane-1-boronate
(R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate 98%
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
(R)-3-Methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methano-1,3,2-benzodioxaborol-2-yl]-1-butanamine 2,2,2-Trifluoroacetate
BoroLeu-(+)-Pinanediol
(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0<
/SUP>
]decan-4-yl]butan-1-amine
2,6<
SUP>
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-
(R)-BoroL
eu-(+)-PinanedioL
(1S,2S,3R,5S)-Pinane-2,3-diol leucineboronate trifluoroacetate salt
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxabor
Bortezomib Intermediate A
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αR,3aS,4S,6S,7aR)-, 2,2,2-trifluoroacetate (1:1)
Ixazomib Impurity 28
2-benzodioxaborole-2-methanamine 2
6-methano-1
7aR)-Hexahydro-3a
8-trimethyl-alpha-(2-methylpropyl)-4
(R)-BoroLeu-(+)-Pinanediol trifluoroacetate (Bortezomib Impurity)
Bortezomib Amino R Isomer
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methy...
(1R)-(S)-Pinanediol 1-ammonium trifluoroacetate-3-methylbutane-1-boronate (TFA)
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate
(1R)-(S)-pinanediol-1-Ammonium Trifluoroacetate-3-methlbutane-1-boronate
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
(1R)-(S)-PINANEDIOL 1-AMMONIUM TRIFLUOROACETATE-3-METHYLBUTANE-1-BORONATE
(R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-triMethylhexahydro-4,6-Methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-aMine 2,2,2-trifluoroacetate
(R) Pinanediol 1-amino-3-methylbutyl borate trifluoroacetate
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αR,3aS,4S,6S,7aR)-,2,2,2-trifluoroacetate (1:1)
(aR,3aS,4S,6S,7aR)- hexahydro -3a,8,8- trimethyl -alpha-(2- methylpropyl) -4,6- methyl bridge -1,3,2- benzodioxolane -2- methylamine 2,2,2- trifluoroacetate
(αR,3aS,4S,6S,7aR)-hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate (1:1)
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-a-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine TFA
(R)-Boroleucine (1S 2S 3R 5S)-(+)-2 3-pinanediol ester trifluoroacetate.
(R)-1-Amino-3-methylbutylboronic acid pinanediol ester trifluoroacetate
(R)-BoroLeu-(+)-Pinanedioltrifluoroacetate salt
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodiox